IN8bio
Blood & Organ Banks · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
350 5th Ave Ste 5330, New York, New York...Phone Number
(646) 600-6438Website
www.in8bio.comRevenue
$29.6 MillionStock Symbol
INABIndustry
About IN8bio
IN8bio is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of gamma-delta T cell therapies for solid and hematological tumors. Utilizing their DeltEx platform, they focus on genetically modified gamma-delta T cells to effectively target and eliminate tumor cells, with a mission to achieve 'CANCER ZERO'. Their lead product candidates include INB-400 and INB-200, both in clinical trials for glioblastoma, and INB-100 for leukemia patients undergoing bone marrow transplantation. The company is supported by a team of experts and a Scientific Advisory Board comprising renowned clinicians and immunologists.Explore more
IN8bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to IN8bio
Compare insights from companies similar to IN8bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
IN8bio Tech Stack
A closer look at the technologies used by IN8bio
Top Blood & Organ Banks Companies
See more top companies
Frequently Asked Questions Regarding IN8bio
Sign Up For FreeTo access detailed company insights
IN8bio is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of gamma-delta T cell therapies for solid and hematological tumors. Utilizing their DeltEx platform, they focus on genetically modified gamma-delta T cells to effectively target and eliminate tumor cells, with a mission to achieve... Read More
